HOME >> MEDICINE >> NEWS
Optimistic outlook may benefit lungs

ATLANTAAn optimistic outlook may improve lung function, suggests a study presented at the American Thoracic Society International Conference in Atlanta on May 20. The study of 670 older men found that those with a more optimistic outlook had significantly higher levels of lung function and a slower rate of decline in lung function than more pessimistic men.

Previous studies have shown a link between optimism and enhanced well-being, while pessimism has been shown to be a risk factor for poor physical health, said lead researcher Rosalind J. Wright, M.D., M.P.H., Instructor in Medicine at Brigham & Women's Hospital and Harvard Medical School in Boston. This is the first study to show such a link specifically between optimism and improved lung function over time.

Dr. Wright said that a persons outlook may somehow influence the bodys immune system processes that play a role in the airway inflammation associated with chronic obstructive pulmonary disease (COPD).

The study suggests there may be reversible factors that may have an impact on patients long-term rate of lung function decline, which has been shown to be related to a persons risk of mortality, Dr. Wright said. Preliminary studies on heart patients have suggested that through behavior modification to change a persons outlook, you can improve a persons mortality risk. Further research may show whether improving a persons outlook can lengthen life and improve the quality of life in patients with lung disease.

The study followed 670 men, the majority of whom were white, and whose average age was 63 years at the beginning of the study. They were followed for an average of eight years, and had an average of three lung exams during that time. Men who were shown to be more optimistic according to a questionnaire derived from the Minnesota Multiphasic Personality Inventory (MMPI) had significantly higher lung function, and a slower rate of decline in lung function compared with more
'"/>

Contact: Cathy Carlomagno
ccarlomagno@thoraic.org
404-222-5302
American Thoracic Society
20-May-2002


Page: 1 2

Related medicine news :

1. New treatment improves long-term outlook for breast cancer survivors
2. New treatment significantly improves long-term outlook for breast cancer survivors
3. Clear outlook: Study finds no link between weather and stroke
4. Stanford study shows now-familiar medications at core of better outlook for depressed patients
5. Positive outlook, sense of self-control can predict new coronary events, says Carnegie Mellon study
6. Unexpected benefit seen in treating HER-2 breast cancer with new preoperative drug combo
7. Corrected metabolism leads to health benefits and weight loss
8. Two years after gene therapy treatments, severe angina patients showed prolonged clinical benefit
9. Artery clearing system does not provide benefit for patients undergoing PCI
10. Older women can benefit from chemotherapy to treat breast cancer
11. Flu vaccination benefits people of any age with high-risk medical conditions

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Optimistic outlook may benefit lungs

(Date:5/19/2013)... Atlanta, GA (PRWEB) May 19, 2013 The ... and 2pm at the Columbus Georgia Convention & Trade Center ... are invited to attend. AMTC auditions are free of charge. ... the starting point for hundreds of successful artists and grads ... new face for European Tombolini , Chris Young - on ...
(Date:5/19/2013)... The Da Vinci robot lawyers at Wright & ... first trial involving a Da Vinci surgical robot lawsuit. ... was filed by the widow of a man who ... robot-assisted prostate removal, according to a report from Bloomberg ... alleges those complication’s hastened his death. (Estate of ...
(Date:5/18/2013)... The American Society for Gastrointestinal Endoscopy (ASGE) will honor ... ninth annual ASGE Crystal Awards on Sunday, May 19, ... year,s event will begin at ... Held in conjunction with Digestive Disease Week (DDW), the ... and scientific pursuit. The event will recognize the 2013 ...
(Date:5/18/2013)... Online watch retailer Time and Gems is offering ... at a fraction of its usual cost. With great deals ... buyers are urged to take advantage of Time and Gems’ ... from a brick-and-mortar store, buyers now have the option of ... unbelievable rates. Although some buyers may have qualms about buying ...
(Date:5/18/2013)... (HealthDay News) -- Just a few extra cups of ... an autoimmune liver disease known as primary sclerosing cholangitis ... Mayo Clinic in Rochester, Minn., found that drinking coffee ... disease, which can lead to cirrhosis of the liver, ... not prove a cause-and-effect relationship. "While rare, ...
Breaking Medicine News(10 mins):Health News:Actors, Models and Talent for Christ Hosting Auditions in Columbus, GA June 1st in Search of Local Talent 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 2Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 3Health News:Da Vinci Surgical Robot Lawyers at Wright & Schulte LLC Note Recent Developments in Da Vinci Robot Lawsuit Trial 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 2Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 3Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 4Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 5Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 6Health News:ASGE and ASGE foundation hold Crystal Awards dinner as part of Digestive Disease Week®, May 19, in Orlando 7Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 2Health News:Time and Gems Offers Buyers the Largest Collection of Rolex Watches Yet 3Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2
(Date:5/17/2013)...  Sanofi (EURONEXT: SAN and NYSE: SNY ) ... , examining the selective JAK2 inhibitor SAR302503 for ... groups. The primary endpoint assessed the proportion of patients ... reported in previous trials, the most common adverse events ... be presented at an upcoming medical congress. ...
(Date:5/17/2013)...  Boston Scientific Corporation (NYSE: BSX ) ... Program May 21-24 in Paris . ... rich and diversified set of data this year at ... global chief medical officer, Boston Scientific.  "The primary endpoint ... NG PROMUS trial, which evaluated our Promus PREMIER ™ ...
(Date:5/16/2013)... , May 16, 2013  PTC Therapeutics, Inc., ... on Form S-1 with the U.S. Securities and Exchange ... of its common stock. The number of shares to ... have not been determined. (Logo:  http://photos.prnewswire.com/prnh/20010919/PTCLOGO ... are acting as joint book-running managers for the offering. ...
Breaking Medicine Technology:Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 2Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 3Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 4Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 5Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8PTC Therapeutics, Inc. Files Registration Statement for Proposed Initial Public Offering 2
Cached News: